Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-15 · accession 0000875320-24-000148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2024-05-15 | VRTX | Schneider Jennifer | Dir | A - Grant | $0.00 | +922 | 922 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-15 | A | A | 922 | $0.00 | 922 | D | — | — | (F1) Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |